Where does Fresenius Vial SAS rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fresenius Vial SAS ranks #6,027 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Fresenius Vial SAS hold?

Fresenius Vial SAS holds 56 US utility patents granted between 2015 and 2025, spanning 20 technology areas.

What is Fresenius Vial SAS's Innovation Score?

Fresenius Vial SAS has an Innovation Score of 42.0 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Fresenius Vial SAS's patent grant rate increasing or decreasing?

Fresenius Vial SAS's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Fresenius Vial SAS's patents?

Fresenius Vial SAS's patents average 12.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Fresenius Vial SAS patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fresenius Vial SAS

Q: What technology areas does Fresenius Vial SAS focus on?

Fresenius Vial SAS's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 40 patents, ranking #177 of 3,490 assignees active in that subclass. Grants appear in 20 CPC subclasses total.

USPTO PatentsView assignee record - 56 granted patents across 20 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fresenius ranks #6,027 of 49,997 tracked US assignees by granted-patent volume, with 56 patents across 20 technology areas.

#6,027
of 49,997 US assignees by volume: Top 32%
by Innovation Score (42.0/100): 12.9
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6027 · Foreign Corporation #6,027 · 56 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 56 grants
UPPER-Q #6,027/49,997
PHOTO-FINISH Enovix
CPC-FOCUS A61M · 20 areas
INNOV-PAR 42.0/100
CLAIMS-RICH 12.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Enovix Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fresenius’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.0 pts (33%) Velocity 4.5 pts (11%) Breadth 15.8 pts (38%) Claim depth 7.7 pts (18%)

Qualcomm Incorporated · highest

85
Bourgault Industries · near

42
Fresenius Vial SAS · this assignee

42
Keeson Technology · near

42
Miracor Medical · near

42
Schleuniger · near

42
3D Lighting… · lowest

7

What this shows Fresenius's Innovation Score is 42.0/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fresenius?

Each dot is one of Fresenius’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fresenius’s own 12.9 claims/patent is at or below the 16.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Fresenius vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fresenius's grants concentrate

Fresenius Vial SAS is a focused PatentsView assignee: 20 CPC subclasses with 71.4% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2021 (12 grants) versus a trough of 1 in 2015. By volume, Fresenius sits between Enovix Corporation and Global Blood Therapeutics, Inc..

Fresenius's three-year grant acceleration

From 2019–2021 to 2022–2024, Fresenius Vial SAS moved from 25 to 17 grants (0.68x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Enovix

56
Flex-n-gate Advan…

56
Foxconn Technolog…

56
Fred Hutchinson C…

56
Garant GP

56
Grip Holdings

56
Guangzhou China S…

56
Global Blood Ther…

56
Fresenius Vial SAS ◀

56

What this shows Fresenius holds 56 patents at rank #6,027, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fresenius

By rank, the assignees closest to #6,027 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Fresenius's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fresenius, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Fresenius ranks #177 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Schleuniger AG 42 Bourgault Industries Ltd. 42 Keeson Technology Corporation Limited 42 Miracor Medical SA 42

Similar claim depth

Nearest assignees by average claims per patent (12.9 here).

Florida A&M University 12.8 avg Hexcel Composites Limited 12.9 avg Zhejiang Shenghui Lighting Co., Ltd. 12.8 avg Humax Co., Ltd. 12.8 avg

Fresenius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fresenius Vial SAS patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	1.8%
2016	2	3.6%
2017	2	3.6%
2018	5	8.9%
2019	3	5.4%
2020	10	17.9%
2021	12	21.4%
2022	7	12.5%
2023	3	5.4%
2024	7	12.5%
2025partial year	4	7.1%

Which technologies does Fresenius Vial SAS patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 40

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 16

F04B - Positive-displacement Machines FOR LIQUIDS; Pumps 5

A61B - DIAGNOSIS; SURGERY; Identification 5

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 4

G06F - Electric Digital Data Processing 3

F16M - Frames, Casings OR Beds OF Engines, Machines OR Apparatus, NOT Specific TO Engines, Machines OR Apparatus Provided FOR ELSEWHERE; STANDS; Supports 2

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 2

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

F16K - VALVES; TAPS; COCKS; ACTUATING-FLOATS; Devices FOR Venting OR Aerating 1

H04B - Transmission 1

H04W - Wireless Communication Networks 1

D06F - Laundering, Drying, Ironing, Pressing OR Folding Textile Articles 1

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 1

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 1

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fresenius Vial SAS's patent record in context - here's where to go next.

Fresenius Vial SAS's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 71.4% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #6,027 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fresenius Vial SAS against Enovix Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.